Prognostic Significance of Receptors for Epidermal Growth Factor, Estrogen, and Progesterone in Ovarian Cancer
β Scribed by GIOVANNI SCAMBIA; PIERLUIGI BENEDETTI PANICI; GABRIELLA FERRANDINA; MARIAGRAZIA DISTEFANO; GIOVANNA SALERNO; MARIA ELISABETTA ROMANINI; GIUSEPPE D'AGOSTINO; ANNA FAGOTTI; SALVATORE MANCUSO
- Book ID
- 119872737
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 297 KB
- Volume
- 784
- Category
- Article
- ISSN
- 0890-6564
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The prognostic value of epidermal growth factor receptor (EGFR) expression and its biological role in estrogen receptorpositive (ER+) and ER-negative (ER-) primary breast cancer is controversial. In this study, distributions of ER, progesterone receptor and EGFR have been established using immunohis
Estrogen (ER) and progesterone receptors (PgR) were evaluated in samples from primary tumors in 539 patients with stage I1 breast cancer participating in a randomized multicenter controlled clinical trial on adjuvant therapy. At the cut-off points of 10 fmol EWmg protein and 30 fmol PgR/ mg protein,